<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhu L</submitter><funding>China Agriculture Research System</funding><funding>SAAS Program for Excellent Research Team 2022</funding><pagination>4133</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9776975</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(24)</volume><pubmed_abstract>&lt;i>Lactobacillus&lt;/i> spp., as probiotics, have shown efficacy in alleviating nonalcoholic fatty liver disease (NAFLD). Here, we screened a new probiotic strain, &lt;i>Lactobacillus salivarius&lt;/i> SNK-6 (&lt;i>L. salivarius&lt;/i> SNK-6), which was isolated from the ileum of healthy Xinyang black-feather laying hens in China. We investigated the beneficial activity of &lt;i>L. salivarius&lt;/i> SNK-6 in a NAFLD model in laying hens and found that &lt;i>L. salivarius&lt;/i> SNK-6 inhibited liver fat deposition and decreased serum triglyceride levels and activity of aspartate transaminase and alanine transaminase. MBOAT2 (membrane-bound O-acyltransferase domain containing 2) was directly targeted by miR-130a-5p, which was downregulated in the liver of NAFLD laying hens but reversed after &lt;i>L. salivarius&lt;/i> SNK-</pubmed_abstract><journal>Cells</journal><pubmed_title>&lt;i>Lactobacillus salivarius&lt;/i> SNK-6 Regulates Liver Lipid Metabolism Partly via the miR-130a-5p/MBOAT2 Pathway in a NAFLD Model of Laying Hens.</pubmed_title><pmcid>PMC9776975</pmcid><funding_grant_id>B-021</funding_grant_id><funding_grant_id>CARS-40-K03</funding_grant_id><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>He D</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Zhu L</pubmed_authors><pubmed_authors>Liao R</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Xiao C</pubmed_authors><pubmed_authors>Yan H</pubmed_authors><pubmed_authors>Yang C</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>Lactobacillus salivarius&lt;/i> SNK-6 Regulates Liver Lipid Metabolism Partly via the miR-130a-5p/MBOAT2 Pathway in a NAFLD Model of Laying Hens.</name><description>&lt;i>Lactobacillus&lt;/i> spp., as probiotics, have shown efficacy in alleviating nonalcoholic fatty liver disease (NAFLD). Here, we screened a new probiotic strain, &lt;i>Lactobacillus salivarius&lt;/i> SNK-6 (&lt;i>L. salivarius&lt;/i> SNK-6), which was isolated from the ileum of healthy Xinyang black-feather laying hens in China. We investigated the beneficial activity of &lt;i>L. salivarius&lt;/i> SNK-6 in a NAFLD model in laying hens and found that &lt;i>L. salivarius&lt;/i> SNK-6 inhibited liver fat deposition and decreased serum triglyceride levels and activity of aspartate transaminase and alanine transaminase. MBOAT2 (membrane-bound O-acyltransferase domain containing 2) was directly targeted by miR-130a-5p, which was downregulated in the liver of NAFLD laying hens but reversed after &lt;i>L. salivarius&lt;/i> SNK-</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-04-08T18:27:26.206Z</modification><creation>2025-04-05T08:47:07.349Z</creation></dates><accession>S-EPMC9776975</accession><cross_references><pubmed>36552896</pubmed><doi>10.3390/cells11244133</doi></cross_references></HashMap>